Clarus Medical Systems, Inc. announced receipt of 510(k) clearance from the FDA.MINNEAPOLIS--(BUSINESS WIRE)--Sept. 18, 1996--Clarus Medical Systems, Inc. today announced receipt of 510(k) clearance from the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) to market a family of reusable fiber optic endoscopes. Designed for less traumatic, non surgical examination of the nose, throat and bronchi bronchi /bron·chi/ (brong“ki) plural of bronchus. Bronchi Two main branches of the trachea that go into the lungs. This then further divides into the bronchioles and alveoli. , these products will support office-based diagnosis and emergency room evaluation of patients' airways. "Clarus will market these products through non-Clarus distribution channels," commented Dennis L. Sellke, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We now offer leading companies established in these fields high-quality, low-cost, ready-to-market capability in airway management In cardiopulmonary resuscitation, anaesthesia, emergency medicine, intensive care medicine and first aid, airway management is the process of ensuring that:
Clarus Medical Systems, Inc. manufactures and markets small-diameter, fiber optic endoscopes for use in minimally invasive medical procedures. CONTACT: Clarus Medical Systems, Inc. Dennis Sellke, 612/525-8400 or 800/359-2372 Fax: 612/525-8656 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion